Načítá se...
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
Adequate glycemic control in type 2 diabetes remains a difficult but achievable goal. The development of new classes of glucose-lowering medications, including in particular the incretin-based therapies, provides an opportunity to utilize combinations of medications which target multiple physiologic...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047989/ https://ncbi.nlm.nih.gov/pubmed/21437106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSOTT.S10195 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|